Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients

References

• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z
   PubMed Web of Science ®Google Scholar
• Hajifathalian K, Ueda P, Lu Y, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015;3:339–355. doi:10.1016/S2213-8587(15)00081-00089
   PubMed Web of Science ®Google Scholar
• Jahangiry L, Farhangi MA, Rezaei F. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Health Popul Nutr. 2017;36:36. doi:10.1186/s41043-017-0114-0
   PubMed Web of Science ®Google Scholar
• Farhangi MA, Jahangiry L. Gender difference in the association between Framingham risk score with cardio-metabolic risk factors and psychological distress in patients with metabolic syndrome. Diabetes Metab Syndr. 2020;14(2):71–75. doi:10.1016/j.dsx.2019.12.009
   PubMed Web of Science ®Google Scholar
• Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):3547–3553. doi:10.1161/CIRCULATIONAHA.105.591792
   PubMed Web of Science ®Google Scholar
• Alwan A. Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: World Health Organization; 2011.
   Google Scholar
• Qiao Q, Gao W, Zhang L, Nyamdorj R, Tuomilehto J. Metabolic syndrome and cardiovascular disease. Ann Clin Biochem. 2007;44(3):232–263. doi:10.1258/000456307780480963
   PubMedGoogle Scholar
• Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–237. doi:10.1242/dmm.001180
   PubMed Web of Science ®Google Scholar
• Wenger NK. Women and coronary heart disease: a century after Herrick understudied, underdiagnosed, and undertreated. Circulation. 2012;126(5):604–611. doi:10.1161/CIRCULATIONAHA.111.086892
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982–3021. Erratum in: J Am Coll Cardiol. 2021 Apr 20;77(15):1958–1959. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005;54(11):3252–3257. doi:10.2337/diabetes.54.11.3252
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689. doi:10.2337/diacare.24.4.683
   PubMed Web of Science ®Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2816. doi:10.1001/jama.288.21.2709
   PubMed Web of Science ®Google Scholar
• Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol. 1998;148:958–966. doi:10.1093/oxfordjournals.aje.a009572
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287(3):356–359. doi:10.1001/jama.287.3.356
   PubMed Web of Science ®Google Scholar
• Grundy SM. Does the metabolic syndrome exist? Diabetes Care. 2006;29(7):1689–1692. doi:10.2337/dc05-2307
   PubMed Web of Science ®Google Scholar
• Turin TC, Shahana N, Wangchuk LZ, et al. The burden of cardiovascular and cerebrovascular diseases and the conventional risk factors in the South Asian Population. Glob Heart. 2013;8:121–130. doi:10.1016/j.gheart.2012.01.001
   PubMedGoogle Scholar
• Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–827. doi:10.1056/NEJMoa1311890
   PubMed Web of Science ®Google Scholar
• Wolf RM, Nagpal M, Magge SN. Diabetes and cardiometabolic risk in South Asian youth: a review. Pediatr Diabetes. 2021;22(1):52–66. doi:10.1111/pedi.13078
   PubMed Web of Science ®Google Scholar
• Adil SO, Islam MA, Musa KI, Shafique K. Prevalence of metabolic syndrome among apparently healthy adult population in Pakistan: a systematic review and meta-analysis. Healthcare. 2023;11(4):531. doi:10.3390/healthcare11040531
   Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• D’Agostino Ralph B, Vasan Ramachandran S, Pencina Michael J, et al. General cardiovascular risk profile for use in primary care. Circulation. 2008;117:743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• Barua L, Banik PC, Islam SM, Faruque M. Application of country-specificGloborisk score to estimate next 10 years risk of cardiovascular diseases and its associated predictors among postmenopausal rural women of Bangladesh: a cross-sectional study in a primary care setting. Lifestyle Med. 2021;2(2):e32. doi:10.1002/lim2.32
   Google Scholar
• Bansal M, Shrivastava S, Mehrotra R, Agarwal V, Kasliwal RR. Low Framingham risk score despite high prevalence of metabolic syndrome in asymptomatic North-Indian population. J Assoc Physicians India. 2009;57:17–22.
   PubMedGoogle Scholar
• Barton TJ, Low DA, Bakker EA, et al. Traditional cardiovascular risk factors strongly underestimate the 5-year occurrence of cardiovascular morbidity and mortality in spinal cord injured individuals. Arch Phys Med Rehabil. 2021;102(1):27–34. doi:10.1016/j.apmr.2020.07.013
   PubMed Web of Science ®Google Scholar
• Grand M, Díaz A, Bia D. Cardiovascular risk prediction equations underestimate risk in people living with HIV: comparison and cut-point redefinition for 19 cardiovascular risk equations. Curr HIV Res. 2022;20:137–151. doi:10.2174/1570162X20666220126124149
   PubMed Web of Science ®Google Scholar
• Pursnani S, Merchant M. South Asian ethnicity as a risk factor for coronary heart disease. Atherosclerosis. 2020;315:126–130. doi:10.1016/j.atherosclerosis.2020.10.007
   PubMedGoogle Scholar
• Martinez-Amezcua P, Haque W, Khera R, et al. The upcoming epidemic of heart failure in South Asia. Circ Heart Fail. 2020;13(10):e007218. doi:10.1161/CIRCHEARTFAILURE.120.007218
   PubMed Web of Science ®Google Scholar
• Mettananda KCD, Gunasekara N, Thampoe R, Madurangi S, Pathmeswaran A. Place of cardiovascular risk prediction models in South Asians; agreement between Framingham risk score and WHO/ISH risk charts. Int J Clin Pract. 2021;75:e14190. doi:10.1111/ijcp.14190
   PubMed Web of Science ®Google Scholar
• Mondal R, Ritu RB, Banik PC. Cardiovascular risk assessment among type-2 diabetic subjects in selected areas of Bangladesh: concordance among without cholesterol-based WHO/ISH, Globorisk, and Framingham risk prediction tools. Heliyon. 2021;7:e07728. doi:10.1016/j.heliyon.2021.e07728
   PubMed Web of Science ®Google Scholar
• Yang W, Ma R, Zhang X, et al. Comparison between metabolic syndrome and the Framingham risk score as predictors of cardiovascular diseases among Kazakhs in Xinjiang. Sci Rep. 2018;8(1):16474. doi:10.1038/s41598-018-34587-1
   PubMedGoogle Scholar